Skip to main content

Teva- Pharmaceutical Industries Ltd

Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Current Price

$35.73

-0.78%

GoodMoat Value

$21.98

38.5% overvalued
Profile
Valuation (TTM)
Market Cap$41.08B
P/E26.27
EV
P/B5.19
Shares Out1.15B
P/Sales2.37
Revenue$17.35B
EV/EBITDA16.43

TEVA (TEVA) — Earnings Call Transcripts

No transcripts available yet

No earnings call transcripts are available for TEVA yet. Check back after the next earnings report.

← Back to TEVA overview